1 Zuckerman AE, "Using the Java language to develop computer based patient records for use on the Internet" 772-776, 1996
2 Teuscher N, "Using sampling “windows” for PK blood samples"
3 Meibohm B, "Pharmacokinetic/pharmacodynamic studies in drug product development" 91 : 18-31, 2002
4 Hyun-Gyu Choi, "Pharmacokinetic Properties of Two Erlotinib 150 mg Formulations with a Genetic Effect Evaluation in Healthy Korean Subjects" Springer Nature 35 (35): 31-43, 2015
5 International Conference on Harmonisation, "ICH Harmonised Tripartite Guideline: Guideline for Good Clinical Practice: E6"
6 US Food and Drug Administration, "Guidance for Industry: Clinical Pharmacology Data to Support a Demonstration of Biosimilarity to a Reference Product"
7 National Library of Medicine, "Clinical Trials"
1 Zuckerman AE, "Using the Java language to develop computer based patient records for use on the Internet" 772-776, 1996
2 Teuscher N, "Using sampling “windows” for PK blood samples"
3 Meibohm B, "Pharmacokinetic/pharmacodynamic studies in drug product development" 91 : 18-31, 2002
4 Hyun-Gyu Choi, "Pharmacokinetic Properties of Two Erlotinib 150 mg Formulations with a Genetic Effect Evaluation in Healthy Korean Subjects" Springer Nature 35 (35): 31-43, 2015
5 International Conference on Harmonisation, "ICH Harmonised Tripartite Guideline: Guideline for Good Clinical Practice: E6"
6 US Food and Drug Administration, "Guidance for Industry: Clinical Pharmacology Data to Support a Demonstration of Biosimilarity to a Reference Product"
7 National Library of Medicine, "Clinical Trials"